Literature DB >> 31483873

Reduced Serum Osteocalcin in High-Risk Alcohol Using People Living With HIV Does Not Correlate With Systemic Oxidative Stress or Inflammation: Data From the New Orleans Alcohol Use in HIV Study.

James Watt1, Jonathan Schuon2, Jacob Davis2, Tekeda F Ferguson1, David A Welsh1, Patricia E Molina1,3, Martin J J Ronis1.   

Abstract

BACKGROUND: HIV infection is now largely a chronic condition as a result of the success of antiretroviral therapy. However, several comorbidities have emerged in people living with HIV (PLWH), including alcohol use disorders and musculoskeletal disorders. Alcohol use has been associated with lower bone mineral density, alterations to circulating bone turnover markers, and hypocalcemia. The pathophysiological basis of bone loss in the PLWH population is unclear but has been suggested to be linked to oxidative stress and inflammation. To test the hypothesis that PLWH consuming excessive alcohol have altered markers of bone turnover and/or calcium homeostasis in association with oxidative stress, we correlated measurements of alcohol consumption with markers of oxidative stress and inflammation, serum calcium concentrations, and measurements of bone turnover, including c-terminal telopeptide cross-links (CTX-1) and osteocalcin.
METHODS: Data were drawn from cross-sectional baseline data from the ongoing New Orleans Alcohol Use in HIV (NOAH) study, comprised of 365 in care PLWH. Alcohol consumption measures (Alcohol Use Disorders Test, 30-day timeline follow-back calendar, and phosphatidylethanol [PEth]) were measured in a subcohort of 40 subjects selected based on highest and lowest PEth measurements. Multivariate linear regression was performed to test the relationships between alcohol consumption and systemic oxidative stress (4-hydroxynonenal; 4-HNE) and inflammation (c-reactive protein; CRP).
RESULTS: Serum calcium and CTX-1 did not differ significantly between the high and low-PEth groups. Individuals in the high-PEth group had significantly lower serum osteocalcin (median low-PEth group: 13.42 ng/ml, inter-quartile range [IQR] 9.26 to 14.99 ng/ml; median high-PEth group 7.39 ng/ml, IQR 5.02 to 11.25 ng/ml; p = 0.0005, Wilcoxon rank-sum test). Osteocalcin negatively correlated with PEth (Spearman r = -0.45, p = 0.05) and self-reported measures after adjusting for covariates. Alcohol consumption showed mild, but significant, positive associations with serum 4-HNE, but not with CRP. Osteocalcin did not correlate with either 4-HNE or CRP.
CONCLUSIONS: In this subcohort of PLWH, we detected significant associations between at-risk alcohol use and osteocalcin, and at-risk alcohol use and serum 4-HNE, suggesting suppression of bone formation independent of increased systemic oxidative stress with increasing alcohol consumption.
© 2019 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; Bone; HIV; Oxidative Stress

Mesh:

Substances:

Year:  2019        PMID: 31483873      PMCID: PMC7489311          DOI: 10.1111/acer.14186

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  63 in total

1.  NOX4 Deletion in Male Mice Exacerbates the Effect of Ethanol on Trabecular Bone and Osteoblastogenesis.

Authors:  James Watt; Alexander W Alund; Casey F Pulliam; Kelly E Mercer; Larry J Suva; Jin-Ran Chen; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2018-04-13       Impact factor: 4.030

2.  The New Orleans Alcohol Use in HIV Study: Launching a Translational Investigation of the Interaction of Alcohol Use with Biological and Socioenvironmental Risk Factors for Multimorbidity in People Living with HIV.

Authors:  David A Welsh; Tekeda Ferguson; Katherine P Theall; Liz Simon; Angela Amedee; Robert W Siggins; Steve Nelson; Meghan Brashear; Donald Mercante; Patricia E Molina
Journal:  Alcohol Clin Exp Res       Date:  2019-03-10       Impact factor: 3.455

3.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

4.  Mortality and quality of life after trochanteric hip fracture.

Authors:  R Willig; S Keinänen-Kiukaaniemi; P Jalovaara
Journal:  Public Health       Date:  2001-09       Impact factor: 2.427

5.  HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk.

Authors:  J Mohamad Fakruddin; Jeffrey Laurence
Journal:  J Biol Chem       Date:  2003-09-15       Impact factor: 5.157

6.  How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk?

Authors:  Joseph Conigliaro; Adam J Gordon; Kathleen A McGinnis; Linda Rabeneck; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

7.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

8.  Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.

Authors:  C Santori; M Ceccanti; D Diacinti; M L Attilia; L Toppo; E D'Erasmo; E Romagnoli; M L Mascia; C Cipriani; A Prastaro; V Carnevale; S Minisola
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

9.  Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women.

Authors:  Jill A Marrone; Gianni F Maddalozzo; Adam J Branscum; Karin Hardin; Lynn Cialdella-Kam; Kenneth A Philbrick; Anne C Breggia; Clifford J Rosen; Russell T Turner; Urszula T Iwaniec
Journal:  Menopause       Date:  2012-09       Impact factor: 2.953

10.  Transient hypoparathyroidism during acute alcohol intoxication.

Authors:  K Laitinen; C Lamberg-Allardt; R Tunninen; S L Karonen; R Tähtelä; R Ylikahri; M Välimäki
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245

View more
  6 in total

1.  Binge Ethanol Exposure in Mice Represses Expression of Genes Involved in Osteoblast Function and Induces Expression of Genes Involved in Osteoclast Differentiation Independently of Endogenous Catalase.

Authors:  Alexandra Denys; Kim B Pedersen; James Watt; Allison R Norman; Michelle L Osborn; Jin-Ran Chen; Cole Maimone; Shana Littleton; Vasilis Vasiliou; Martin J J Ronis
Journal:  Toxicol Sci       Date:  2022-01-24       Impact factor: 4.109

2.  Osteocalcin Alleviates Lipopolysaccharide-Induced Acute Inflammation via Activation of GPR37 in Macrophages.

Authors:  Zhengjiang Qian; Chunhua Liu; Hongchao Li; Haiyang Yang; Jianhao Wu; Jing Liu; Yanjiao Li; Xuhui Chen; Jianyang Xu; Xiang Li
Journal:  Biomedicines       Date:  2022-04-27

3.  Chronic Ethanol Feeding in Mice Decreases Expression of Genes for Major Structural Bone Proteins in a Nox4-Independent Manner.

Authors:  Kim B Pedersen; Michelle L Osborn; Alex C Robertson; Ashlee E Williams; James Watt; Alexandra Denys; Katrin Schröder; Martin J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2020-03-25       Impact factor: 4.030

4.  Impact of Alcohol on Bone Health, Homeostasis and Fracture repair.

Authors:  Jonathan M Eby; Farah Sharieh; John J Callaci
Journal:  Curr Pathobiol Rep       Date:  2020-07-28

5.  Diurnal Variation in Biomarkers of Exposure to Endocrine-Disrupting Chemicals and Their Association with Oxidative Damage in Norwegian Adults: The EuroMix Study.

Authors:  Samuel Olushola Abimbola; Christina Xeni; Amrit Kaur Sakhi; Behzad Heibati; Trine Husøy; Hubert Dirven; Konstantinos C Makris
Journal:  Toxics       Date:  2022-04-07

6.  Alcohol and Bone Turnover Markers among People Living with HIV and Substance Use Disorder.

Authors:  Theresa W Kim; Alicia S Ventura; Michael R Winter; Timothy C Heeren; Michael F Holick; Alexander Y Walley; Kendall J Bryant; Richard Saitz
Journal:  Alcohol Clin Exp Res       Date:  2020-03-02       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.